Literature DB >> 22526124

[Tachycardias. What must the emergency physician know?].

H-J Trappe1.   

Abstract

Clinical characteristics and the surface electrocardiogram (ECG) are important diagnostic tools for patients with tachycardias. Tachycardias are characterized by a ventricular heart rate > 100/min and have been divided into those with narrow (QRS width < 0.12 s) or wide QRS complex tachycardias (QRS width ≥ 0.12 s). In broad complex tachycardias, AV dissociation, negative or positive concordant pattern in V(1)-V(6), a notch in V(1) and qR complexes in V(6) in tachycardias with left bundle-branch block morphologies are findings indicating ventricular tachycardia (VT). In addition, an R/S relation <1 in V(6) favors VT when right bundle-branch block tachycardia morphologies are present. By analyzing the surface ECG in the right way with a systematic approach, the specificity and sensitivity of correctly identifying supraventricular tachycardia or VT can be > 95%. Therapeutic options in supraventricular or ventricular tachyarrhythmias are preferentially adenosine, ajmaline, amiodarone, and adrenaline. If antiarrhythmic drugs fail, electric cardioversion using short-acting anesthesia is recommended.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22526124     DOI: 10.1007/s00063-012-0079-0

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  9 in total

Review 1.  Atrial fibrillation: established and innovative methods of evaluation and treatment.

Authors:  Hans-Joachim Trappe
Journal:  Dtsch Arztebl Int       Date:  2012-01-09       Impact factor: 5.594

2.  Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation.

Authors:  Paul Dorian; Dan Cass; Brian Schwartz; Richard Cooper; Robert Gelaznikas; Aiala Barr
Journal:  N Engl J Med       Date:  2002-03-21       Impact factor: 91.245

Review 3.  [Modern pharmacotherapy of supraventricular and ventricular cardiac arrhythmia. An update for conventional therapy].

Authors:  D Steven; B Lutomsky; T Rostock; S Willems
Journal:  Internist (Berl)       Date:  2006-10       Impact factor: 0.743

4.  Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation.

Authors:  P J Kudenchuk; L A Cobb; M K Copass; R O Cummins; A M Doherty; C E Fahrenbruch; A P Hallstrom; W A Murray; M Olsufka; T Walsh
Journal:  N Engl J Med       Date:  1999-09-16       Impact factor: 91.245

5.  Out-of-hospital cardiac arrest--the relevance of heart failure. The Maastricht Circulatory Arrest Registry.

Authors:  Anton P M Gorgels; Claudia Gijsbers; Jacqueline de Vreede-Swagemakers; Aimee Lousberg; Hein J J Wellens
Journal:  Eur Heart J       Date:  2003-07       Impact factor: 29.983

6.  Treating critical supraventricular and ventricular arrhythmias.

Authors:  Hans-Joachim Trappe
Journal:  J Emerg Trauma Shock       Date:  2010-04

Review 7.  [Regular tachycardia with broad QRS complex: differential diagnosis on 12-lead ECG].

Authors:  B Schumacher; S Spehl; A Langbein; A Schade; S Kerber; M Koller
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2009-04-18

8.  Delayed time to defibrillation after in-hospital cardiac arrest.

Authors:  Paul S Chan; Harlan M Krumholz; Graham Nichol; Brahmajee K Nallamothu
Journal:  N Engl J Med       Date:  2008-01-03       Impact factor: 91.245

9.  A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation.

Authors:  Volker Wenzel; Anette C Krismer; H Richard Arntz; Helmut Sitter; Karl H Stadlbauer; Karl H Lindner
Journal:  N Engl J Med       Date:  2004-01-08       Impact factor: 91.245

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.